Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.12 +0.01 (+0.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Alx Oncology Holdings (ALXO) Price to Sales (2020 - 2022)

Updated

Alx Oncology Holdings' Price to Sales was 5626.15 in Q1 2021, up 317.3% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Price to Sales (2020 - 2022) Analysis & Trends

For FY2020, Price to Sales at Alx Oncology Holdings came in at 1348.09.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Alx Oncology Holdings 153.42 Mn -230.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 107.65
Sep 30, 2022 156.49
Jun 30, 2022 288.14
Mar 31, 2022 2,361.16
Dec 31, 2021 13,215.39
Sep 30, 2021 66,451.49
Jun 30, 2021 95,868.95
Mar 31, 2021 5,626.15
Dec 31, 2020 1,348.09
Sep 30, 2020 467.44
API Access

Alx Oncology Holdings Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALXO&period=max&api_key=YOUR_API_KEY